Mechanisms underlying the hepatotoxic effects of ecstasy.
3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is a worldwide illegally used amphetamine-derived designer drug known to be hepatotoxic to humans. Jaundice, hepatomegaly, centrilobular necrosis, hepatitis and fibrosis represent some of the adverse effects caused by MDMA in the liver. Although there is irrefutable evidence of MDMA-induced hepatocellular damage, the mechanisms responsible for that toxicity remain to be thoroughly clarified. One well thought-of mechanism imply MDMA metabolism in the liver into reactive metabolites as responsible for the MDMA-elicited hepatotoxicity. However, other factors, including MDMA-induced hyperthermia, the increase in neurotransmitters efflux, the oxidation of biogenic amines, polydrug abuse pattern, and environmental features accompanying illicit MDMA use, may increase the risk for liver complications. Liver damage patterns of MDMA in animals and humans and current research on the mechanisms underlying the hepatotoxic effects of MDMA will be highlighted in this review.
Carvalho
Márcia
M
Faculty of Health Sciences, University Fernando Pessoa, Rua Carlos da Maia, 296, 4200/150 Porto, Portugal. mcarv@ufp.edu.pt
Pontes
Helena
H
Remião
Fernando
F
Bastos
Maria L
ML
Carvalho
Félix
F
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury / Q000503:physiopathology*; D006213:Hallucinogens / Q000633:toxicity; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000503:physiopathology*; D008954:Models, Biological; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000633:toxicity*
D006213:Hallucinogens; D018817:N-Methyl-3,4-methylenedioxyamphetamine